1 Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054-1062, doi:10.1016/S0140-6736(20)30566-3 (2020).
2 Freund, Y. et al. Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department. JAMA 317, 301-308, doi:10.1001/jama.2016.20329 (2017).
3 Namendys-Silva, S. A. Respiratory support for patients with COVID-19 infection. Lancet Respir Med 8, e18, doi:10.1016/S2213-2600(20)30110-7 (2020).
4 Raoult, D., Zumla, A., Locatelli, F., Ippolito, G. & Kroemer, G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress 4, 66-75, doi:10.15698/cst2020.04.216 (2020).
5 Wu, Z. & McGoogan, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, doi:10.1001/jama.2020.2648 (2020).
6 Li, T., Lu, H. & Zhang, W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 9, 687-690, doi:10.1080/22221751.2020.1741327 (2020).
7 Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033-1034, doi:10.1016/S0140-6736(20)30628-0 (2020).
8 Bloomgarden, Z. T. Diabetes and COVID-19. J Diabetes 12, 347-348, doi:10.1111/1753-0407.13027 (2020).
9 Dietz, W. & Santos-Burgoa, C. Obesity and its Implications for COVID-19 Mortality. Obesity (Silver Spring) 28, 1005, doi:10.1002/oby.22818 (2020).
10 Forsberg, E. M. et al. Data processing, multi-omic pathway mapping, and metabolite activity analysis using XCMS Online. Nat Protoc 13, 633-651, doi:10.1038/nprot.2017.151 (2018).
11 Shen, B. et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell, doi:10.1016/j.cell.2020.05.032 (2020).
12 de Groot, V., Beckerman, H., Lankhorst, G. J. & Bouter, L. M. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 56, 221-229, doi:10.1016/s0895-4356(02)00585-1 (2003).
13 Madji Hounoum, B. et al. Analytical methodology for metabolomics study of adherent mammalian cells using NMR, GC-MS and LC-HRMS. Anal Bioanal Chem 407, 8861-8872, doi:10.1007/s00216-015-9047-x (2015).
14 Assenov, Y., Ramirez, F., Schelhorn, S. E., Lengauer, T. & Albrecht, M. Computing topological parameters of biological networks. Bioinformatics 24, 282-284, doi:10.1093/bioinformatics/btm554 (2008).
15 Xia, J. & Wishart, D. S. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res 38, W71-77, doi:10.1093/nar/gkq329 (2010).
16 Muscogiuri, G., Pugliese, G., Barrea, L., Savastano, S. & Colao, A. Comentary: Obesity: The "Achilles heel" for COVID-19? Metabolism 108, 154251, doi:10.1016/j.metabol.2020.154251 (2020).
17 Guo, W. et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev, e3319, doi:10.1002/dmrr.3319 (2020).
18 Richardson, S. et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, doi:10.1001/jama.2020.6775 (2020).
19 Yang, J. et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94, 91-95, doi:10.1016/j.ijid.2020.03.017 (2020).
20 Hui, D. S. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91, 264-266, doi:10.1016/j.ijid.2020.01.009 (2020).
21 Giamarellos-Bourboulis, E. J. et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe, doi:10.1016/j.chom.2020.04.009 (2020).
22 Ye, B. et al. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 55, E003, doi:10.3760/cma.j.cn115330-20200223-00116 (2020).
23 Mamas, M., Dunn, W. B., Neyses, L. & Goodacre, R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 85, 5-17, doi:10.1007/s00204-010-0609-6 (2011).
24 Fukuwatari, T. & Shibata, K. Nutritional aspect of tryptophan metabolism. Int J Tryptophan Res 6, 3-8, doi:10.4137/IJTR.S11588 (2013).
25 Cervenka, I., Agudelo, L. Z. & Ruas, J. L. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. Science 357, doi:10.1126/science.aaf9794 (2017).
26 Wang, Q., Liu, D., Song, P. & Zou, M. H. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Front Biosci (Landmark Ed) 20, 1116-1143, doi:10.2741/4363 (2015).
27 South, A. M., Diz, D. I. & Chappell, M. C. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 318, H1084-H1090, doi:10.1152/ajpheart.00217.2020 (2020).
28 Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477-481, doi:10.1038/nature11228 (2012).
29 Ghosh, H. S., McBurney, M. & Robbins, P. D. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One 5, e9199, doi:10.1371/journal.pone.0009199 (2010).
30 Dhar, D. & Mohanty, A. Gut microbiota and Covid-19- possible link and implications. Virus Res 285, 198018, doi:10.1016/j.virusres.2020.198018 (2020).
31 Neavin, D. R., Liu, D., Ray, B. & Weinshilboum, R. M. The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases. Int J Mol Sci 19, doi:10.3390/ijms19123851 (2018).
32 Minhas, P. S. et al. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nat Immunol 20, 50-63, doi:10.1038/s41590-018-0255-3 (2019).
33 Farsalinos, K., Angelopoulou, A., Alexandris, N. & Poulas, K. COVID-19 and the nicotinic cholinergic system. Eur Respir J, doi:10.1183/13993003.01589-2020 (2020).
34 Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130, 2620-2629, doi:10.1172/JCI137244 (2020).
35 Danchin, A. & Marliere, P. Cytosine drives evolution of SARS-CoV-2. Environ Microbiol, doi:10.1111/1462-2920.15025 (2020).
36 Linden, J., Koch-Nolte, F. & Dahl, G. Purine Release, Metabolism, and Signaling in the Inflammatory Response. Annu Rev Immunol 37, 325-347, doi:10.1146/annurev-immunol-051116-052406 (2019).
37 Chandler, J. D. et al. Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice. Am J Physiol Regul Integr Comp Physiol 311, R906-R916, doi:10.1152/ajpregu.00298.2016 (2016).
38 Lazarowski, E. R., Sesma, J. I., Seminario-Vidal, L. & Kreda, S. M. Molecular mechanisms of purine and pyrimidine nucleotide release. Adv Pharmacol 61, 221-261, doi:10.1016/B978-0-12-385526-8.00008-4 (2011).
39 Bae, D. H., Lane, D. J. R., Jansson, P. J. & Richardson, D. R. The old and new biochemistry of polyamines. Biochim Biophys Acta Gen Subj 1862, 2053-2068, doi:10.1016/j.bbagen.2018.06.004 (2018).
40 Liang, M. et al. l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway. Food Chem Toxicol 115, 315-328, doi:10.1016/j.fct.2018.03.029 (2018).
41 Poillet-Perez, L. et al. Autophagy maintains tumour growth through circulating arginine. Nature 563, 569-573, doi:10.1038/s41586-018-0697-7 (2018).
42 Nakayasu, E. S. et al. MPLEx: a Robust and Universal Protocol for Single-Sample Integrative Proteomic, Metabolomic, and Lipidomic Analyses. mSystems 1, doi:10.1128/mSystems.00043-16 (2016).